saplin

Compare funds

Axis ELSS- Tax Saver vs Quant ELSS Tax Saver

Both are elss funds. Over the last 3 years Axis ELSS- Tax Saver returned 12.7% a year and Quant ELSS Tax Saver 15.6%, against a category median of 12.8%. Axis ELSS- Tax Saver costs 1.02% a year and Quant ELSS Tax Saver 1.29%. On the saplin Score Axis ELSS- Tax Saver rates 7.4 (Neutral) and Quant ELSS Tax Saver 6.7 (Neutral) within their category. 9.4% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

Axis ELSS- Tax SaverQuant ELSS Tax SaverCategory median
saplin Score (0–10)7.4 Neutral6.7 Neutral—
1-year return4.3%13.0%2.0%
3-year return, a year12.7%15.6%12.8%
5-year return, a year6.6%14.6%11.3%
Volatility (standard deviation)15.5%18.4%15.7%
Sharpe ratio0.450.570.46
Beta0.921.060.95
Upside capture9711497
Downside capture9310297
Expense ratio (Direct)1.02%1.29%1.11%
Fund size₹32,144 cr₹13,377 cr₹2,054 cr
Number of holdings743160
Top 10 holdings, share of fund38.3%62.6%40.0%
Portfolio P/E29.034.324.6
Lead managerShreyash Devalkar (3 yrs)——
Launched29 Dec 20098 Mar 2000—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

Axis ELSS- Tax Saver and Quant ELSS Tax Saver have 9.4% of their portfolios in the same stocks (5 holdings in common, portfolios as of 30 Oct 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsAxis ELSS- Tax SaverQuant ELSS Tax Saver
Bharti Airtel4.97%5.22%
Divi's Laboratories2.73%5.53%
Sona BLW Precision Forgings1.66%1.00%
Premier Energies0.40%3.57%
Aurobindo Pharma0.34%8.75%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.